Tyra Biosciences, Inc.
(TYRA - NASDAQ)
36,92 USD
📋 Profilo Aziendale

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer.

|